Skip to main content

Health and Medicine

Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


Lung disorder drug regimen found harmful

Oct. 31, 2011—Longtime treatment for IPF ineffective and even dangerous.

Read more


Protein family key to aging linked to suppressing tumors

Oct. 28, 2011—The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.

Read more


Vanderbilt doctors to screen patients taking statins for genetic risk factors

Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

Read more


Stopping colitis, STAT

Oct. 27, 2011—Study suggests a new therapeutic target in ulcerative colitis.

Read more


Growth factor boosts beta cells

Oct. 21, 2011—A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.

Read more


Information flow reduced in psychosis

Oct. 21, 2011—Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.

Read more


Initiative to help ‘translate’ diabetes research advances

Oct. 21, 2011—The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.

Read more


Predicting hospital readmission is risky business: study

Oct. 18, 2011—Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.

Read more


Supplements don’t help lung injury patients

Oct. 13, 2011—Supplements did not improve outcomes of patients with acute lung injury.

Read more


Diversity key in antibody repertoire

Oct. 7, 2011—Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

Read more


Fungus toxin gets in the way in DNA

Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.

Read more


Upcoming Events

MORE EVENTS »